タイトル無し
スポンサーリンク
概要
- 論文の詳細を見る
The health risk from hypercholesterolemia in Japan has been overemphasized for years. When discussing the risk of hypercholesterolemia, the famous figure is often cited that shows an exponential relationship between serum cholesterol levels and the risk of coronary heart disease (Guideline for Diagnosis and Treatment of Hyperlipidemias in Adults, 1997, Japan Atherosclerosis Society). This figure, consisting of several sets of epidemiological data, recently turned out to be based on unreliable data and data manipulation. One of the misleading epidemiological studies in that figure incorporated a surprisingly large number of familial hypercholesterolemic subjects. Familial hypercholesterolemia should be excluded from this kind of epidemiological studies, because the disease is rare (0.2%), and the incidence of coronary heart disease is exceptionally high. Almost all the recently performed large-scale epidemiological studies in Japan showed that higher cholesterol levels, like 240-260 mg/dL (6.2-6.7 mmol/L) or 240-280 mg/dL (6.2-7.3 mmol/L), are safer than lower cholesterol levels in terms of all-cause mortality. This is partly due to a very low coronary heart disease incidence in Japan. Prescribing lipid-lowering medicines to subjects with 240 to 260 mg/dL of cholesterol, which is recommended by the newest guideline (2004) of Japan Atherosclerosis Society, faces the paradox of treating those who are least likely to die. The guideline for hypercholesterolemia must be set by those researchers who have not received any assistance from cholesterol-lowering drugs makers.
- 日本脂質栄養学会の論文
日本脂質栄養学会 | 論文
- 高地トレーニングにおける赤血球膜機能に及ぼす魚油濃縮物投与の効果
- COX阻害剤の使用実態 (話題:リノール酸摂取量について)
- 脂質栄養:脂質と認知症--日本脂質栄養学会第16回大会モリス博士基調講演の記録
- n-3系多価不飽和脂肪酸の循環・脳機能改善作用機序の解明
- 血清コレステロール値をどう見るか--酸化能を考慮した設定の可能性